Adriane Elizabeth Schiano, MD in Arlington, TX - Medicare Ophthalmology

Adriane Elizabeth Schiano, MD is a medicare enrolled "Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery" physician in Arlington, Texas. She graduated from medical school in 2016 and has 8 years of diverse experience with area of expertise as Ophthalmology. She is a member of the group practice Arlington Ophthalmology Association Pllc and her current practice location is 350 E Interstate 20, Arlington, Texas. You can reach out to her office (for appointments etc.) via phone at (817) 784-0222.

Adriane Elizabeth Schiano is licensed to practice in Texas (license number S5767) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033565429.

Contact Information

	Adriane Elizabeth Schiano, MD
	350 E Interstate 20, Arlington, TX 76018-1119
	(817) 784-0222
	Not Available

Physician's Profile

Full Name	Adriane Elizabeth Schiano
Gender	Female
Speciality	Ophthalmology
Experience	8 Years
Location	350 E Interstate 20, Arlington, Texas
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Adriane Elizabeth Schiano graduated from medical school in 2016

NPI Data:

NPI Number: 1033565429
Provider Enumeration Date: 05/04/2016
Last Update Date: 07/27/2021

Medicare PECOS Information:

PECOS PAC ID: 6507260304
Enrollment ID: I20210802000260

Medical Identifiers

Medical identifiers for Adriane Elizabeth Schiano such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033565429	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	S5767 (Texas)	Secondary
207WX0200X	Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery	S5767 (Texas)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Arlington Ophthalmology Association Pllc	2668379876	17

News Archive

Adult sickle cell drug hydroxyurea proves effective in young children

A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

It has been known for some time that the extracts of the Cannabis plant, just like synthetic cannabinoids and those produced by the brain itself, join up with type 1 (CB1) cannabinoid receptors located in the nerve endings of the neurons, and inhibit the release of chemical messengers (neurotransmitters) in the communication areas between the nerve cells.

Research provides insight into how harmless nasal bacteria help protect from diseases

Staphylococcus aureus is a common colonizer of the human body. Although, one quarter of the U.S. population live with the bacteria and never get sick, having S. aureus present in the nostrils is a risk for infections that range in severity from mild skin to life- threatening MRSA infections.

SDI selected for third consecutive time as key monoclonal antibody provider

SDI (Strategic Diagnostics Inc.), a leading provider of biotechnology-based products and services for a broad range of life science, food safety, and industrial applications, today announced it has been selected again by Science Applications International Corporation - Frederick (SAIC-F) to develop monoclonal antibodies for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative (CPTC: http://proteomics.cancer.gov).

LJI study could provide important target for autoimmune disease interventions

Follicular helper T cells (Tfh cells), a rare type of T cells, are indispensable for the maturation of antibody-producing B cells. They promote the proliferation of B cells that produce highly selective antibodies against invading pathogens while weeding out those that generate potentially harmful ones.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Adriane Elizabeth Schiano allows following entities to bill medicare on her behalf.

Entity Name	Arlington Ophthalmology Association Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1639276843 PECOS PAC ID: 2668379876 Enrollment ID: O20031216000677

News Archive

Adult sickle cell drug hydroxyurea proves effective in young children

A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

Research provides insight into how harmless nasal bacteria help protect from diseases

SDI selected for third consecutive time as key monoclonal antibody provider

LJI study could provide important target for autoimmune disease interventions

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adriane Elizabeth Schiano is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Adriane Elizabeth Schiano, MD 5232 Scarborough Ln, Dallas, TX 75287-5422 Ph: (713) 818-0058	Adriane Elizabeth Schiano, MD 350 E Interstate 20, Arlington, TX 76018-1119 Ph: (817) 784-0222

News Archive

Adult sickle cell drug hydroxyurea proves effective in young children

A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

Research provides insight into how harmless nasal bacteria help protect from diseases

SDI selected for third consecutive time as key monoclonal antibody provider

LJI study could provide important target for autoimmune disease interventions

Ophthalmology Doctors in Arlington, TX

Dr. Huy Minh Tran, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 101 W Randol Mill Rd, Ste 120, Arlington, TX 76011 Phone: 817-861-3937 Fax: 817-861-3914
Barbara A Nugent, MD PA Ophthalmology Medicare: Medicare Enrolled Practice Location: 3125 Matlock Rd, Ste 105, Arlington, TX 76015 Phone: 817-465-6664 Fax: 817-468-9289
Dr. Nirmal Saran, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2726 Matlock Rd, Ste A, Arlington, TX 76015 Phone: 817-461-2893 Fax: 817-276-0271
Dr. Michael Alan Blair, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W Randol Mill Rd Ste 201, Arlington, TX 76012 Phone: 817-277-6433 Fax: 817-277-9086
Nikisha Ashok Kothari, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W Randol Mill Rd Ste 101, Arlington, TX 76012 Phone: 817-261-9625
Patrick D. Williams, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W Randol Mill Rd, Suite 101, Arlington, TX 76012 Phone: 817-261-9625 Fax: 817-261-9586

Adriane Elizabeth Schiano, MD - Medicare Ophthalmology in Arlington, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Adult sickle cell drug hydroxyurea proves effective in young children

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

Research provides insight into how harmless nasal bacteria help protect from diseases

SDI selected for third consecutive time as key monoclonal antibody provider

LJI study could provide important target for autoimmune disease interventions

Medicare Reassignments

Adult sickle cell drug hydroxyurea proves effective in young children

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

Research provides insight into how harmless nasal bacteria help protect from diseases

SDI selected for third consecutive time as key monoclonal antibody provider

LJI study could provide important target for autoimmune disease interventions

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Adult sickle cell drug hydroxyurea proves effective in young children

Cannabinoid receptors regulate memory processes by modulating mitochondrial energy metabolism

Research provides insight into how harmless nasal bacteria help protect from diseases

SDI selected for third consecutive time as key monoclonal antibody provider

LJI study could provide important target for autoimmune disease interventions

Ophthalmology Doctors in Arlington, TX